Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07224243

Impact of Intraoperative Oxygenation Practices on Patient Outcomes

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
54,000 (estimated)
Sponsor
Frederic T Billings IV · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This multicenter, cluster-randomized, cluster-crossover clinical trial evaluates the impact of three intraoperative FiO2 (Fraction of Inspired Oxygen) oxygenation strategies-lower (FiO₂ 0.21-0.40), intermediate (FiO₂ 0.40-0.80), and higher (FiO₂ 0.80-1.00)-on postoperative organ injury and mortality in adult surgical patients. The trial aims to determine the optimal oxygenation strategy to improve perioperative outcomes.

Detailed description

The Intraop Ox trial will enroll adult patients undergoing surgery with tracheal intubation. Participating hospitals will be randomly assigned (as a unit) to administer one of three oxygenation strategies during maintenance anesthesia (lower FiO₂ \[0.21-0.40\], intermediate FiO₂ \[0.40-0.80\], or higher \[FiO₂ 0.80-1.00\] each period (month). The primary outcome is a composite of organ injury (acute kidney injury, myocardial injury, lung injury, stroke) or death within 30 days. Secondary outcome is 30-day mortality. Exploratory outcomes are individual components of the composite primary endpoint, surgical site infection, length of stay, and hypoxemia. The study is conducted under a waiver of informed consent due to minimal incremental risk of participating and impracticability of obtaining consent in this cluster-randomized design.

Conditions

Interventions

TypeNameDescription
OTHERLower FiO2FiO₂ 0.21-0.40 or lowest FiO₂ to maintain SpO₂ ≥ 94% during maintenance anesthesia
OTHERIntermediate FiO2FiO₂ 0.40-0.80 or lowest FiO₂ to maintain SpO₂ ≥ 94% during maintenance anesthesia
OTHERHigher FiO2FiO₂ \> 0.80 to maintain SpO₂ ≥ 94% during maintenance anesthesia

Timeline

Start date
2025-12-01
Primary completion
2028-02-01
Completion
2028-04-01
First posted
2025-11-04
Last updated
2026-04-07

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT07224243. Inclusion in this directory is not an endorsement.